Healthcare / Medical Instruments & SuppliesUpdated 2026-05-10 22:07 UTC

LON/0NJ5 stock hub

LON/0NJ5 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0NJ5is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

635.2M

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0NJ5

In the news

Latest news · LON/0NJ5

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E15.3

P25 12.9P50 16.9P75 23.5

Trailing P/E15

P25 15.9P50 22.9P75 35.8

ROE11.6

P25 -54.2P50 2.1P75 13.7

ROIC10.3

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0NJ5 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

224

Groups with data

Currency

EUR

Showing 224 of 224 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Italy
Country code	UK
Employees	3,400
Employees Change	-245%
Employees Change Percent	-6.72
Enterprise value	EUR 684.2M
Exchange	London Stock Exchange
Financial currency	EUR
First seen	2026-05-10
Industry	Medical Instruments & Supplies
Isin	IT0004604762
Last refreshed	2026-05-10
Market cap	EUR 635.2M
Price	EUR 1.78
Price currency	EUR
Rev Per Employee	261,706.28x
Sector	Healthcare
Sic	3851
Symbol	lon/0NJ5
Website	https://www.safilogroup.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	6.68%
EV Earnings	16.13x
EV/EBIT	12.34x
EV/EBITDA	8.01x
EV/FCF	9.65x
EV/Sales	0.81x
FCF yield	11.16%
Forward P/E	15.29x
P/B ratio	1.81x
P/E ratio	14.97x
P/S ratio	0.74x
PE Ratio10 Y	36.78x
PE Ratio3 Y	17.2x
PE Ratio5 Y	45.75x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	6.53%
EBITDA Margin	8.92%
FCF margin	8.26%
Gross margin	60.94%
Gross Profit	EUR 522.8M
Gross Profit Growth	-0.42%
Gross Profit Growth Q	-0.93%
Gross Profit Growth3 Y	0.11%
Gross Profit Growth5 Y	-0.11%
Net Income	EUR 42.4M
Net Income Growth	118.15%
Net Income Growth Q	47.74%
Net Income Growth Years	1%
Net Income Growth3 Y	193.9%
Net Income Growth5 Y	31.26%
Pretax Margin	6.81%
Profit Margin	4.95%
Profit Per Employee	EUR 12,944
Profitable Years	1
ROA	5.01
Roa5y	3.4
ROCE	12.93
ROE	11.61
Roe5y	6.19
ROIC	10.29
Roic5y	7.4

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-8.21%
Cagr15y	-8.9%
Cagr1y	137.22%
Cagr3y	10.01%
Cagr5y	12.88%
EPS Growth	115.4
EPS Growth Q	47.59
EPS Growth Years	1
EPS Growth3 Y	198.4
EPS Growth5 Y	30.91
FCF Growth	25.72%
FCF Growth Q	2.2%
FCF Growth3 Y	23.04%
FCF Growth5 Y	31.89%
OCF Growth	17.66%
OCF Growth Q	0.27%
OCF Growth3 Y	18.46%
OCF Growth5 Y	21.5%
Revenue Growth	-0.99x
Revenue Growth Q	-3.36x
Revenue Growth Years	0x
Revenue Growth3 Y	-0.77x
Revenue Growth5 Y	-1.41x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 1.23
Assets	EUR 662.1M
Cash	EUR 45.5M
Current Assets	EUR 387.8M
Current Liabilities	EUR 227M
Debt	EUR 85.7M
Debt EBITDA	EUR 0.99
Debt Equity	EUR 0.24
Debt FCF	EUR 1.21
Equity	EUR 351.6M
Interest Coverage	8.98
Liabilities	EUR 310.5M
Long Term Assets	EUR 274.3M
Long Term Liabilities	EUR 83.5M
Net Cash	EUR -40.2M
Net Cash By Market Cap	EUR -6.33
Net Debt EBITDA	EUR 0.53
Net Debt Equity	EUR 0.11
Net Debt FCF	EUR 0.57
Tangible Book Value	EUR 214.6M
Tangible Book Value Per Share	EUR 0.52
WACC	10.31

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.71
Inventory Turnover	2.01
Net Working Capital	EUR 152.1M
Quick ratio	1
Working Capital	EUR 162.2M
Working Capital Turnover	EUR 4.09

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.69%
Dividend per share	EUR 0
Last Dividend	EUR 1.35

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-57.55%
1Y total return	137.08%
200-day SMA	1.73
3Y total return	33.13%
50-day SMA	1.71
50-day SMA vs 200-day SMA	50under200
5Y total return	83.25%
All Time High	59.55
All Time High Change	-97%
All Time High Date	2007-11-06
All Time Low	0.51
All Time Low Change	252.08%
All Time Low Date	2020-10-29
ATR	0.05
Beta	1.23
Ch YTD	-7.08
High	1.82
High52	2.18
High52 Date	2026-02-04
High52ch	-18.28%
Low	1.77
Low52	0.8
Low52 Date	2025-05-09
Low52ch	137.08%
Ma50ch	4.21%
Price vs 200-day SMA	2.94%
RSI	58.45
RSI Monthly	59.51
RSI Weekly	51.55
Sharpe ratio	1.69x
Sortino ratio	3.21
Total Return	-0.69%
Tr YTD	-7.06
Tr15y	-75.31%
Tr1m	3.84%
Tr1w	10.77%
Tr3m	-14.11%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 56M
Operating Income Growth	-0.76
Operating Income Growth Q	-4.32
Operating Income Growth3 Y	12.35
Operating Income Growth5 Y	7.31
Operating margin	6.53

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	209,113,298%
Net Borrowing	-35,455,053.8
Shares Institutions	21.18%
Shares Qo Q	2%
Shares Yo Y	0.69%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 70.9M
Average Volume	7,642.8x
Bv Per Share	0.82
CAPEX	EUR -7.3M
Ch10y	-76.33
Ch15y	-86.23
Ch1m	3.84
Ch1w	10.74
Ch1y	137.1
Ch3m	-14.11
Ch3y	33.13
Ch5y	65.19
Ch6m	0.11
Change	8.09%
Change From Open	-0.67
Close	1.65
Days Gap	8.78
Depreciation Amortization	20,330,839.8
Dollar Volume	2,560
Earnings Date	2026-05-06
EBIT	EUR 56M
EBITDA	EUR 76.5M
EPS	EUR 0.1
F Score	7
FCF	EUR 70.9M
FCF EV Yield	10.36x
Financing CF	-51,107,094
Fiscal Year End	December
Founded	1,878
Goodwill	26,774,460.8
Graham Number	1.62717
Graham Upside	-8.79
Income Tax	EUR 16.4M
Investing CF	-20,550,488
Is Primary Listing	0
Last Earnings Date	2026-05-06
Last Report Date	2025-12-31
Last Split Date	2010-05-10
Last Split Type	Reverse
Lynch Fair Value	EUR 2.98
Lynch Upside	66.99
Ma150	1.83
Ma150ch	-2.41%
Ma20	1.69
Ma20ch	5.56%
Net CF	4,121,090
Next Earnings Date	2026-08-03
Open	1.8
P FCF Ratio	8.96
P OCF Ratio	8.12
Position In Range	24.39
Ppne	96,911,230
Price Date	2026-05-08
Price EBITDA	EUR 8.3
Ptbv Ratio	2.96
Relative Volume	0.18x
Revenue	857,873,191x
Tax By Revenue	1.91x
Tax Rate	28.01%
Tr6m	0.11%
Volume	1,435
Z Score	2.58

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/0NJ5 pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0NJ5 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0NJ5?

Insider, institutional, and short-interest positioning.

Institutional ownership

+21.2%

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.7%

Negative means the company is buying back shares.

Technical

LON/0NJ5 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

58.4

Neutral momentum band

Price vs 200-day MA

+2.9%

50/200-day relationship not available

Beta (5Y)

1.23

More volatile than the market

Sharpe ratio

1.69

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0NJ5

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0NJ5 stock rating?

lon/0NJ5 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0NJ5 analysis?

The full report lives at /stocks/lon/0NJ5/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0NJ5?

The latest report frames lon/0NJ5 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0NJ5 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.